erythromycin
erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.
Cross Reference
Introduction
To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with erythromycin?
erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (35)
- J. Antimicrob. Chemother. (18)
- J. Pharmacol. Exp. Ther. (2)
- Others (29)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with erythromycin
PubChem Associated disorders and diseases
What pathways are associated with erythromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with erythromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
What functions are associated with erythromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with erythromycin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
What genes are associated with erythromycin?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (19)
- J. Antimicrob. Chemother. (10)
- Drug Metab. Dispos. (5)
- Others (29)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with erythromycin?
Mouse Model
Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).
Knock-out
Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
NCBI Entrez Crosslinks
All references with erythromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Mathis C and Malbert CH | Changes in pyloric resistance induced by erythromycin. | 1998 | Neurogastroenterol. Motil. | pmid:9614671 |
| Bourrat E et al. | [Rosacea with ocular involvement in a child]. | 1996 | Ann Dermatol Venereol | pmid:9615130 |
| Syphilis--recommended treatment schedules, 1976. | 1976 | Am Fam Physician | pmid:961559 | |
| Krone LV | The importance of multiple antibiotic coverage for hospitalized patients when the community acquired pneumonia is Legionnaire's disease. | 1998 | WMJ | pmid:9617308 |
| Kudoh S et al. | Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. | 1998 | Am. J. Respir. Crit. Care Med. | pmid:9620913 |
| Kruppa A et al. | Immediate reaction to roxithromycin and prick test cross-sensitization to erythromycin and clarithromycin. | 1998 | Dermatology (Basel) | pmid:9621142 |
| Widdowson CA and Klugman KP | Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa. | 1998 Apr-Jun | Emerging Infect. Dis. | pmid:9621199 |
| Rosato A et al. | A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin. | 1998 | Antimicrob. Agents Chemother. | pmid:9624482 |
| Muli F and Struthers JK | Use of a continuous-culture biofilm system to study the antimicrobial susceptibilities of Gardnerella vaginalis and Lactobacillus acidophilus. | 1998 | Antimicrob. Agents Chemother. | pmid:9624489 |
| Kataja J et al. | Different erythromycin resistance mechanisms in group C and group G streptococci. | 1998 | Antimicrob. Agents Chemother. | pmid:9624500 |
| Reinert RR et al. | In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany. | 1998 | Antimicrob. Agents Chemother. | pmid:9624505 |
| Roblin PM and Hammerschlag MR | In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae. | 1998 | Antimicrob. Agents Chemother. | pmid:9624507 |
| Souli M et al. | In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens. | 1998 | Int. J. Antimicrob. Agents | pmid:9624540 |
| Wirsing von König CH et al. | Factors influencing the spread of pertussis in households. | 1998 | Eur. J. Pediatr. | pmid:9625336 |
| Wandel C et al. | Effect of CYP3A inhibition on vesnarinone metabolism in humans. | 1998 | Clin. Pharmacol. Ther. | pmid:9630823 |
| Stassi DL et al. | Ethyl-substituted erythromycin derivatives produced by directed metabolic engineering. | 1998 | Proc. Natl. Acad. Sci. U.S.A. | pmid:9636144 |
| Novaes AB et al. | Immediate implants placed into infected sites: a histomorphometric study in dogs. | 1998 May-Jun | Int J Oral Maxillofac Implants | pmid:9638015 |
| Havlik J and Holý M | [Erythromycin stearate Spofa--coated tablets for pediatric practice]. | 1976 | Cesk Pediatr | pmid:963828 |
| Shimatani T | Involvement of cholinergic motor neurons in pharmacological regulation of gastrointestinal motility by glucagon in conscious dogs. | 1997 Aug-Oct | J Smooth Muscle Res | pmid:9639019 |
| Oyarzún E et al. | Antibiotic treatment in preterm labor and intact membranes: a randomized, double-blinded, placebo-controlled trial. | 1998 May-Jun | J Matern Fetal Med | pmid:9642605 |